Type II diabetic Goto-Kakizaki (GK) rats were insulin-resistant in euglycemic-hyperinsulinemic damp studies. We therefore examined insulin signaling systems in control Wistar and diabetic GK rats. Glycerol-3-phosphate acyltransferase (G3PAT), which is activated by headgroup mediators released from glycosyl-phosphatidylinositol (GPI), was activated by insulin in intact and cell-free adipocyte preparations of control, but not diabetic, rats. A specific chiro-inositol-containing inositol phosphoglycan (IPG) mediator, prepared from beef liver, bypassed this defect and comparably activated G3PAT in cell-free adipocyte preparations of both diabetic GK and control rats. A myo-inositol-containing IPG mediator did not activate G3PAT. Relative to control adipocytes, labeling ofGPI by [3H]guc was diminished by 50% and insulin failed to stimulate GPI hydrolysis in GK adipocytes. In contrast to GPI-dependent G3PAT activation, insulin-stimulated hexose transport was intact in adipocytes and soleus and gastrocnemius muscles of the GK rat, as was insulin-induced activation of mitogen-activated protein kinase and protein kinase C. We conclude that (i) chiro-inositolconining IPG mediator activates G3PAT during insulin action, (ii) diabetic GK rats have a defect in synthesizing or relasing functional chiro-inositol-containing IPG, and (iii) defective IPG-regulated intracellular glucose metabolism contributes importantly to insulin resistance in diabetic GK rats.
Insulin uses multiple signaling systems controlled through insulin receptor tyrosine kinase activation. Tyrosine phosphorylation ofinsulin receptor substrate 1 (1) , pp6O (2) , SHC, and other proteins induces their interaction with src homology region 2-containing proteins-e.g., phosphatidylinositol 3-kinase (3) or growth factor receptor-bound protein 2 (4)-thus sequentially activating SOS (5), ras (6, 7) , raf (8) , mitogen-activated protein kinase (MAPK) kinase (9) , MAPK (10) , and insulin-stimulated protein kinase (11) . Insulin also stimulates the hydrolysis of glycosyl-phosphatidylinositol (GPI) (12) (13) (14) and phosphatidylcholine (PC) (15) (16) (17) (18) (19) . GPI hydrolysis requires a pertussis toxin-sensitive G protein (15, 20, 21) , whereas ras (19, 22) or other factors may be important for PC hydrolysis. As a result of PC or GPI hydrolysis, diacylglycerol increases (12, 15-17, 20, 23) and protein kinase C (PKC) is activated (24) (25) (26) (27) (28) (29) (30) . GPI hydrolysis also releases inositol phosphoglycan (IPG) headgroups, including those containing chiro-inositol or myo-inositol (14, 31) .
With respect to glucose homeostasis, IPG mediators activate glycogen synthase (GS) (32) , pyruvate dehydrogenase (PDH) (14, 33) , and glycerol-3-phosphate acyltransferase (G3PAT) (21, 34) . Thus, insulin may regulate intracellular glucose metabolism through IPGs, which activate protein phosphatases (35) . A role for IPG in glucose transport is supported by some (36) , but not other (37) , findings. Glucose transport may be regulated by protein kinases (PKs) (38)-e.g., PKC (39) , MAPK, or other PKs. chiro-Inositolcontaining IPG (C-IPG), rather than myo-inositol-containing IPG (M-IPG), may activate GS and PDH through their respective phosphatases (14, 40) . As reported here, C-IPG also activates G3PAT, an insulin-sensitive enzyme that (i) controls de novo phospholipid synthesis and (ii) can be conveniently studied in both intact and cell-free systems (21, 34) .
Defects in signaling systems that regulateglucose transport or intracellular glucose metabolism may cause insulin resistance in type II diabetes mellitus. Presently, we studied (i) insulininduced activation of G3PAT to reflect IPG signaling, and (ii) glucose transport and PK signaling in nonobese, type II diabetic, Goto-Kakizaki (GK) rats. The GK genetic rat model is particularly relevant to understanding human type II diabetes since (i) defects in insulin secretion and resistance are both seen at 2-4 weeks of age in the GK rat (41); (ii) the pattern of low chiro-inositol and increased myo-inositol in the urine ofthe GK rat (42) is similar to that in type II diabetic humans (43) and monkeys (44) ; (iii) IPG mediator-dependent PDH activation is deficient in GK rat liver membranes (42) ; (iv) low urinary chiro-inositol excretion in the monkey (44) correlates directly with the severity of insulin resistance as measured by glucose disposal ("M"), GS activation in muscle and fat, and glycogen phosphorylase inactivation in muscle; and (v) C-LPG, but not M-IPG, mediator bioactivity from human hemodialysate, urine, and autopsy muscle is deficient in type U diabetics (45) . We now report that (i) insulin-induced activation of G3PAT is defective in the diabetic GK rat, apparently due to deficient synthesis and release of C-IPG; and (ii) a defect in C-IPG-regulated intracellular glucose metabolism, rather than PK-regulated glucose transport, may play a more primary pathogenetic role in insulin resistance in certain tissues of diabetic GK rats.
EXPERIMENTAL METHODS Except where indicated, fed 200-g male rats were used.
Holtzman Wistar rats were used as nondiabetic controls since GK rats were derived from the Wistar strain. [Note that (i) activates (via a decrease in K.) G3PAT through a factor that is released from plasma membranes by insulin or phosphatidylinositol-specific phospholipase C and operates through an NaF-inhibitable enzyme, presumably a phosphatase.
IPG mediators were prepared from beef liver (see refs. 14 and 46). The C-IPG mediator was purified by HPLC on a protein Pak 60 column (Waters), using H20 as a solvent, yielding a single peak of ultraviolet-absorbing (at 195 nm) material that eluted with a retention time of 18 min and coincided with bioactivity. IPG mass was quantitated by its chiro-inositol or myo-inositol content, measured by GC/MS and Dionex HPLC after acid hydrolysis (47) . Both Further structural studies will be reported separately.
As described (49, 50) , glycolipids were labeled by overnight culture of adipocytes with [3H]glucosamine (also converted to galactosamine and mannosamine), yielding labeled glycolipids that migrated just behind phosphatidylinositol during TLC and decreased rapidly with insulin or phosphatidylinositol-specific phospholipase C treatment.
Total body glucose utilization and hepatic glucose output were quantitated during euglycemic-hyperinsulinemic clamp studies in anesthetized rats, as described (51, 52 (53) .
Adipocyte MAPK activation was measured as described (54) , using myelin basic protein as substrate in assays of whole-cell lysates, and, as confirmation, in myelin basic protein-containing gels (i.e., 42-kDa MAPK). PKC-a translocation was measured by Western analysis (see ref. 29) . RESULTS As in previous studies (21, 34) , in both BC3H1 myocytes and control Wistar rat adipocytes, insulin provoked 2-to 3-fold increases in G3PAT activity in intact cells and cell-free homogenates (Fig. 1) . Moreover, in cell-free homogenates of both cell types, 2.5 juM C-IPG (from beef liver) provoked 2-fold increases in G3PAT activity (Fig. 1). (Note that this concentration of C-IPG was optimal.) In contrast, M-IPG mediator, at similar concentrations, was inactive in stimulating G3PAT. Nitrous acid treatment led to a complete loss of the C-IPG mediator. As further confirmation that insulin activated G3PAT through an IPG mediator, anti-IPG antiserum (provided by Guillermo Romero; see refs. 48 and 55 regarding epitope specificity) inhibited the G3PAT-activating effects of both insulin and C-IPG in adipocyte homogenates, whereas preimmune serum was without effect (Table 1) .
In contrast to control adipocytes, insulin failed to activate G3PAT in intact or cell-free preparations of adipocytes from diabetic GK rats (Fig. 1) . This suggested that insulin may not provoke increases in IPG mediators in GK adipocytes. However, to our surprise, C-IPG failed to stimulate G3PAT activity in cell-free preparations of GK adipocytes (Fig. 1) (Bottom) . The values given are the means ± SE of (n) assays. CON, control. (Fig. 2) . Moreover, the stimulatory effects of C-IPG on G3PAT in insulin-primed diabetic GK rat adipocyte preparations were comparable to those of insulin and C-IPG in nondiabetic Wistar rat adipocyte preparations. Thus, insulin priming fully reversed a defect distal to C-IPG but had no effect on a defect proximal to C-IPG.
As in adipocytes of older 200-g diabetic GK rats, insulin failed to activate G3PAT in adipocytes of younger, 100-g, diabetic GK rats. With hyperinsulinemic Zucker rats, insulin provoked comparable 2.5-fold increases in G3PAT activity in adipocytes of both obese 900-g (fa/fa) and nonobese (fa/+) rats. When Wistar and GK adipocytes were cultured for 20 hr in DMEM (see refs. 49 and 50), insulin activated G3PAT nearly 2-fold in cultured Wistar, but not diabetic GK, adipocytes. Thus, the defect in insulin-induced G3PAT activation in diabetic GK rat adipocytes is present at an early age, is not due to hyperinsulinemia alone, and is not reversed by short-term culture ex vivo. 
FIG. 2. Effects of insulin (INS) and C-IPG mediator (MED) on
G3PAT activation in cell-free homogenates of insulin-treated diabetic GK rats. Experiments were conducted as in Fig. 1 , except that these GK rats were treated in vivo with subcutaneous injections of 2 units of NPH insulin for 6 consecutive days prior to experimental use in vitro. The values shown are the means ± SE of (n) assays.
Because insulin failed to release a functional IPG mediator in GK adipocytes, we questioned whether there were defects in the biosynthesis or stimulated hydrolysis of glycolipid precursors of IPGs. As compared to controls, overnight PHlglucosamine labeling ofglycolipids (presumably GPIs) was diminished by 50%o, and, moreover, insulin failed to stimulate GPI hydrolysis in GK rat adipocyte preparations (Fig. 3) .
In contrast to G3PAT activation, insulin effects (peak 2-fold increases at 10 min) on MAPK activity in adipocytes of 120-g GK rats were indistinguishable from effects observed in adipocytes of 120-g control Wistar rats (younger rats were used for MAPK activation, as older rats were less responsive to insulin). Similarily, insulin at 10-20 min provoked comparable increases in membrane PKC-a in control Wistar (62% ± 12%; n = 14) and GK (59o + 9o; n = 16) rat adipocytes. Thus, insulin-induced activation of MAPK and PKC was not compromised in GK adipocytes.
To verify that GK rats were insulin-resistant, we studied glucose metabolism during euglycemic-hyperinsulinemic clamp conditions. At two insulin infusion rates producing moderate and marked hyperinsulinemia (see ref. 52 ), total glucose utilization was decreased by 29%o and 42%, and hepatic glucose output was increased by 69%o and 72%, in diabetic GK rats, as compared to control Wistar rats (Table 2 ). Glucose accumulation in the gastrocnemius muscle during the final 30 min of the clamp was decreased by 69%o in the GK rat (Table 2 ). This defect in glucose accumulation contrasts with normal uptake of 2-DOG (i.e., transport and trapping as nonmetabolizable 2-DOG-6-PO4) during a lO-min period in comparable clamp conditions (Table 2 ; see below). Presumably, the decrease in glucose accumulation in the GK gastrocnemius reflects that, after uptake, glucose that is not stored or oxidized may be metabolized and released as pyruvate/ lactate/alanine, particularly in type II diabetes (57) .
Since insulin failed to activate G3PAT in adipocytes of diabetic GK rats, it was surprising to find that insulin was very effective in stimulating hexose transport (2- Proc. Natl. Acad. Sci. USA 91 (1994) 11043 (4) muscle, nmol/g of muscle/30 min Food was withheld for [16] [17] [18] [19] [20] hr before the experiment. Rats were anesthetized with isoflurane, and body temperature was maintained at 37C. Physiological saline (along with D-[6-3H]glucose for groups A and B) was infused at constant rates to deliver 0, 4, or 40 milliunits of insulin per min, as indicated. (Note that GK rats were not studied at the 0 insulin infusion rate, as these rats are hyperglycemic and moderately hyperinsulinemic in their "basal" fasting state, and large amounts of insulin are required to render them euglycemic.) In all groups, glucose (measured every 5-10 min) was brought to 150 mg/dl (± 10%) and held constant at this level for at least 60 min prior to, and during, a 30-min sampling period, by varying the rate ofglucose infusion, which, at equilibrium, was generally "3-fold greater in control Wistar rats, as compared to diabetic GK rats. The total duration ofeach study was 3-4 hr. In groups A and B, the measured serum glucose-specific activities were constant during the final 30 min (glucose utilization was therefore calculated by dividing the [3H]glucose infusion rate by the final serum glucose specific 3H radioactivity). In group C, 2-DOG uptake (i.e., transport and conversion to nonmetabolizable 2-DOG-6PO4) ( uptake) in these same GK rat adipocytes (Fig. 4) increased 2-and 3-fold at the two insulin infusion rates in control Wistar rats; also note that it was not possible to measure "basal uptake" at euglycemic levels in GK rats). 
DISCUSSION
The present findings provide direct evidence that insulin activates G3PAT through an IPG mediator released from GPI in the plasma membrane. Previously, we reported that both insulin and phosphatidylinositol-specific phospholipase C stimulate the release of a (Mr < 5000) water-soluble substance that stimulates microsomal G3PAT (21, 34 ). Presently we found that a purified C-IPG mediator from beef liver directly activated G3PAT in cell-free preparations of BC3H1 myocytes and Wistar rat adipocytes. The exact chemical structure of this C-IPG mediator awaits further study.
Most importantly, adipocytes from GK rats manifested a marked deficiency in insulin-stimulated G3PAT activation but responded well with respect to hexose transport. Thus, certain insulin-sensitive signaling pathways were deficient in the GK rat, whereas other signaling pathways were preserved. More specifically, insulin-induced hydrolysis of GPI was markedly impaired, in the face of normal activation of both MAPK and PKC in adipocytes of the diabetic GK rat.
There were at least two defects in the GPI hydrolysis signaling pathway in GK rat adipocytes. One, more distal, involved the response of G3PAT to C-IPG and was reversible with 6-day insulin priming. The other, more proximal, was not reversed by insulin but was fully bypassed by exogenously added C-IPG mediator and was best explained by a failure of insulin to synthesize and/or release the C-IPG mediator.
Along with impaired G3PAT activation, PH]glucosamine labeling of GPI precursors for IPG mediators was deficient in GK adipocytes, and insulin failed to stimulate GPI hydrolysis in GK adipocyte preparations. Further studies will be required to determine whether GPI abnormalities in the GK rat are due to decreased substrate availability or a defective biosynthetic enzyme(s), GPI-specific phospholipase C coupling factor, or other factor.
It was surprising that insulin resistance in the GK rat did not involve a defect in insulin-stimulated hexose transport, at least as measured in adipocytes, soleus muscles in vitro, and gastrocnemius muscle in vivo, at moderate to saturating insulin concentrations. Thus, hyperglycemia in the GK rat appears to be due to combined defects in insulin secretion and diminished 
, I
I insulin effects on both hepatic glucose production and nonhepatic intracellular glucose metabolism. Indeed, in the gastrocnemius muscle, we observed decreased accumulation of glucose, most likely reflecting storage defects, in the face of normal glucose transport. Accordingly, in addition to G3PAT, insulin-induced activation of adipocyte PDH in vitro (42) and muscle GS and GS phosphatase in vivo (58) are impaired in the diabetic GK rat. This is not to say that insulin-regulated glucose transport is not diminished in the diabetic GK rat, but such diminution may reflect insulin deficiency or feedback from intracellular defects and could also be apparent at lower insulin concentrations or in tissues not presently studied.
In summary, a purified C-IPG mediator, like insulin, activated G3PAT in cell-free preparations of Wistar rat adipocytes and BC3H1 myocytes. This suggests that insulininduced hydrolysis of GPI and release of IPG mediators from the plasma membrane is largely responsible for the activation of microsomal G3PAT. In addition, insulin-induced activation of G3PAT, but not hexose transport, was severely compromised in adipocytes of the diabetic GK rat. Moreover, this defect in G3PAT activation was fully bypassed by addition of a C-IPG mediator to cell-free preparations of GK rat adipocytes. Thus, a specific insulin-regulated signaling pathway-GPI synthesis and hydrolytic release of C-IPG mediators-is defective and contributes importantly to insulin resistance in the type II diabetic GK rat.
